Ravenquest BioMed (CSE: RQB) (OTC: Coming Soon) - Investor Dashboard
RavenQuest BioMed – Management Team
The RavenQuest BioMed Inc’s Management team is comprised of entrepreneurs with experience in medical marijuana, security, pharmaceutical, marketing, and technology businesses. Additional management and operational staff will be brought on as the Issuer continues to roll out its business plan.
Chief Executive Officer
Mr. Robinson is a recognized specialist in the cannabis sector and has worked directly with the CL2G Group’s clients and Health Canada in all stages of the application and licensing phases under the ACMPR and its predecessor legislation, the MMPR. Mr. Robinson’s consultancy team has extensive experience in building design, municipal bylaw compliance, heating, ventilation and air conditioning, cannabis growing and drying strategies, security, data collection and analysis, and project funding. His consultancy firm has proven knowledge and project execution in federal and provincial regulated industries including oil & gas, utilities, financial, federal agencies & departments and health care. Mr. Robinson is a B.C. Licensed Security Consultant, Black Belt Six Sigma Certified and past president of the BC Regional Council of the Canadian Security Association.
Dave Cross, CPA, CGA
Chief Financial Officer
Mr. Cross is a partner at Cross Davis & Company LLP Chartered Professional Accountants (“Cross Davis”) which provides accounting and consulting services to publicly traded companies. Mr. Cross has 20 years of accounting experience and has been a partner of Cross Davis for seven years. In addition to serving as the CFO of RavenQuest, he also serves as the CFO of several companies listed on the TSX and TSX Venture Exchange.
Marla K. Ritchie
Ms. Ritchie brings over 25 years’ experience in public markets working as an Administrator and Corporate Secretary specializing in resource based exploration companies. She has been the Corporate Secretary for Wealth Minerals Ltd. since August 2006.
Hendrik (Henk) Van Alphen
Mr. Hendrik (Henk) Van Alphen is a proven leader with experience in funding, building and operating numerous companies in the resource sector. Mr. Van Alphen brings extensive experience in international mergers & acquisitions. He has been involved in financing and transactions totalling well over $1 billion over his career. He has extensive experience with Canadian public companies having held executive management and board positions with multiple issuers.
Mr. Chris Bechtel brings to the Issuer over 30 years’ experience, as an executive, entrepreneur and consultant, managing and advising businesses from start-ups to divisions of large Fortune 500 companies. Mr. Bechtel is the former chairman of Supreme Pharmaceuticals, Inc., one of first Canadian public companies in the cannabis sector.
Mr. Tony Drescher, CPA, CMA has over 35 years’ experience as an executive and consultant in various industries including mining, telecommunications, technology and waste management. He currently serves on the Board of Directors of several private and public companies.
Dr. Jorge Bonet is the Director of the Atrial Fibrillation Clinic at The Royal Columbian Hospital and runs his own private cardiology practice. He has received international awards for original research as well as grant support from different granting agencies including the Canadian Heart Foundation and St. Boniface Research Foundation. Dr. Bonet has been a principal investigator in multiple major international randomized clinical studies.
Significant Insider Ownership
George Robinson, CEO
7mm shares, 560K warrants
Anton Drescher, Director
3.04mm shares, 800K warrants
Noel Avila, President of AGB
Hendrik Van Alphen, Director
Chris Bechtel, Director
Jorge Bonet, Director
1mm shares, 400K warrants
Marla Ritchie, Corporate Secretary
David Cross, CFO
New Cannabis Ventures in partnership with due diligence platform 420Investor, is the definitive source for fact-based, data-driven, financial information and relevant company news for qualified publicly traded cannabis companies. NCV extracts and parses only the most important content. Information is provided “as is” and solely for informational purposes, not for trading or advice. RavenQuest BioMed, Inc., is a client of NCV Media, LLC. Read our full disclaimer.